Company intelligence / Profile preview

S4 Medical

Cleveland, Ohio, United Statess4medical.com ↗

Ownership: Private
Development stage: Commercial

Overview

S4 Medical has developed the ESolution device to protect the esophagus during catheter ablation procedures for atrial fibrillation. Human studies have shown successful deviation of the esophagus with no acute complications or injuries related to either the procedure or use of ESolution. The company received FDA 510(k) clearance in November 2024 and has begun commercialization.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on S4 Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S4 Medical.

Explore the full profile